Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Katz
Artur
A
Calabrich
Aknar
A
Saad
Everardo D
ED
D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D009570:Nitriles / Q000627:therapeutic use; D017697:Premenopause; D013629:Tamoxifen / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D017273:Goserelin; D000077384:Anastrozole